Literature DB >> 31832994

Neuropsychological Profile in Children with Posterior Fossa Tumors with or Without Postoperative Cerebellar Mutism Syndrome (CMS).

Silvia Cámara1, Mª Concepción Fournier2, Patricia Cordero3, Javier Melero2, Fernando Robles4, Borja Esteso2, Mª Teresa Vara4, Serafín Rodríguez4, Álvaro Lassaletta5, Marcelo Budke6.   

Abstract

Cerebellar mutism syndrome (CMS) is a common surgical sequela in children following posterior fossa tumor (PFT) resection. Here, we analyze the neuropsychological features associated with PFT in children, focusing particularly on the differential profiles associated with the presence or absence of CMS after surgery. We further examine the effect of post-resection treatments, tumor type, and presence/absence of hydrocephalus on surgical outcome. Thirty-six patients diagnosed with PFT (19 with and 17 without CMS) and 34 age- and gender-matched healthy controls (HCs) were recruited. A comprehensive neuropsychological evaluation was conducted in all patients postoperatively and in HCs, including an assessment of general cognitive ability, motor skills, perception, language, memory, attention, executive functions, and academic competence. CMS was found to be a clinical marker of lower neuropsychological profile scores across all cognitive domains except auditory-verbal processing and visual memory tasks. PFT patients not presenting CMS exhibited milder impairment in intellectual functioning, motor tasks, reasoning, language, verbal learning and recall, attention, cognitive executive functions, and academic competence. High-grade tumors were associated with slower processing speed and verbal delayed recall as well as alterations in selective and sustained attention. Hydrocephalus was detrimental to motor functioning and nonverbal reasoning. Patients who had undergone surgery, chemotherapy, and radiotherapy presented impaired processing speed, verbal learning, and reading. In addition to the deleterious effects of PFT, post-resection PFT treatments have a negative cognitive impact. These undesired consequences and the associated tumor-related damage can be assessed using standardized, long-term neuropsychological evaluation when planning rehabilitation.

Entities:  

Keywords:  Cerebellar mutism syndrome; Cerebellum; Neuropsychological assessment; Pediatric tumors; Posterior fossa tumors

Year:  2020        PMID: 31832994     DOI: 10.1007/s12311-019-01088-4

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  5 in total

1.  Evaluating the diagnostic validity of the cerebellar cognitive affective syndrome (CCAS) in pediatric posterior fossa tumor patients.

Authors:  Doris Hoffmann-Lamplmair; Ulrike Leiss; Andreas Peyrl; Irene Slavc; Thomas Czech; Alexandra Gram; Thomas Pletschko
Journal:  Neurooncol Adv       Date:  2022-05-12

Review 2.  Cognitive Risk in Survivors of Pediatric Brain Tumors.

Authors:  Ade Oyefiade; Iris Paltin; Cinzia R De Luca; Kristina K Hardy; David R Grosshans; Murali Chintagumpala; Donald J Mabbott; Lisa S Kahalley
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

3.  Development and application of a diagnostic and severity scale to grade post-operative pediatric cerebellar mutism syndrome.

Authors:  Federica S Ricci; Rossella D'Alessandro; Alessandra Somà; Anna Salvalaggio; Francesca Rossi; Sara Rampone; Giorgia Gamberini; Chiara Davico; Paola Peretta; Mario Cacciacarne; Pierpaolo Gaglini; Paolo Pacca; Giulia Pilloni; Paola Ragazzi; Daniele Bertin; Stefano G Vallero; Franca Fagioli; Benedetto Vitiello
Journal:  Eur J Pediatr       Date:  2021-10-14       Impact factor: 3.860

4.  Reading in Children Who Survived Cerebellar Tumors: Evidence from Eye Movements.

Authors:  Sofia Mironets; Marina Shurupova; Anna Dreneva
Journal:  Vision (Basel)       Date:  2022-02-06

5.  Spatiotemporal changes in along-tract profilometry of cerebellar peduncles in cerebellar mutism syndrome.

Authors:  Sebastian M Toescu; Lisa Bruckert; Rashad Jabarkheel; Derek Yecies; Michael Zhang; Christopher A Clark; Kshitij Mankad; Kristian Aquilina; Gerald A Grant; Heidi M Feldman; Katherine E Travis; Kristen W Yeom
Journal:  Neuroimage Clin       Date:  2022-03-30       Impact factor: 4.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.